Tilray Brands (TLRY) Research & Development (2017 - 2026)
Tilray Brands (TLRY) reported Research & Development of $62000.0 for Q1 2026, down 94.36% on a YoY basis from $1.1 million in Q1 2025, and down 20.51% quarter-over-quarter from $78000.0 in Q4 2025.
Tilray Brands (TLRY) Research & Development (2017 - 2026) Analysis & Trends
Tilray Brands has reported Research & Development for 10 years, with the latest figure at $62000.0 in Q1 2026.
- For the quarter ending Q1 2026, Research & Development fell 94.36% year-over-year to $62000.0; the trailing twelve-month figure through Feb 2026 stood at $5.6 million (up 409.14% YoY), and the FY2025 full-year result was $5.7 million, up 800.31% from the prior year.
- Research & Development for Q1 2026 stood at $62000.0, down from $78000.0 in the prior quarter.
- The five-year high for Research & Development was $5.5 million in Q2 2025, with the low at -$3.1 million in Q2 2024.
- Historically, Research & Development has averaged $385764.7 across 5 years, with a median of $106000.0 in 2024.
- Annual changes were most pronounced in 2023 — Research & Development sank 311.15% — and 2025, when it surged 937.74%.
- Tilray Brands' Research & Development stood at $1.2 million in 2022, then gained by 12.72% to $1.4 million in 2023, then sank by 95.63% to $60000.0 in 2024, then increased by 30.0% to $78000.0 in 2025, then dropped by 20.51% to $62000.0 in 2026.
- The last three Research & Development figures came in at $62000.0 (Q1 2026), $78000.0 (Q4 2025), and $41000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 222.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 180.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 138.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | 934,363.43 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 296.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 97.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | 103.35 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 39.38 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 46.94 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn | 62,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 62,000.00 |
| Nov 30, 2025 | 78,000.00 |
| Aug 31, 2025 | 41,000.00 |
| May 31, 2025 | 5.47 Mn |
| Feb 28, 2025 | 1.10 Mn |
| Nov 30, 2024 | 60,000.00 |
| Aug 31, 2024 | 105,000.00 |
| May 31, 2024 | -3.09 Mn |
| Feb 29, 2024 | 106,000.00 |
| Nov 30, 2023 | 1.37 Mn |
| Aug 31, 2023 | 79,000.00 |
| May 31, 2023 | -2.80 Mn |
| Feb 28, 2023 | 1.10 Mn |
| Nov 30, 2022 | 1.22 Mn |
| Aug 31, 2022 | 166,000.00 |
| May 31, 2022 | 1.33 Mn |
| Feb 28, 2022 | 164,000.00 |
| Nov 30, 2021 | 515,000.00 |
| Aug 31, 2021 | 790,000.00 |
| May 31, 2021 | 2.24 Mn |